Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
01/31/2002 | CA2412544A1 Polypeptide delivery ii-2 |
01/30/2002 | EP1176189A1 Stem cell-like cells |
01/30/2002 | EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
01/30/2002 | EP1175506A2 Compound screening method |
01/30/2002 | EP0956009B1 Treatment of neurodegenerative conditions with nimesulide |
01/30/2002 | EP0888373A4 Smooth muscle cell lim protein |
01/30/2002 | CN1333828A Compositions and methods for increasing bone mineralization |
01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
01/24/2002 | WO2002006535A2 Method for breeding disease resistant domesticated fowl |
01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
01/24/2002 | WO2002005842A2 Preventing airway mucus production by administration of egf-r antagonists |
01/24/2002 | WO2002005634A2 Transgenic animal and methods |
01/24/2002 | WO2002005633A1 P300 transgenic animal |
01/24/2002 | WO2001060794A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
01/24/2002 | WO2001046258A3 Transporters and ion channels |
01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
01/24/2002 | US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells |
01/24/2002 | US20020010948 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
01/24/2002 | US20020010947 Transgenic mouse model of human neurodegenerative disease |
01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
01/24/2002 | US20020009704 Preparing oocyte for cryogenic suspension; suspend sample in freeze resistant nutrient, rinse, drop onto solid solid surface with good heat conductivity |
01/24/2002 | US20020009452 Method for altering undesirable immune responses to polypeptides |
01/24/2002 | US20020008105 Container for delivery of useful organisms |
01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
01/24/2002 | CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists |
01/23/2002 | EP1173571A2 Human ion channel proteins |
01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
01/17/2002 | WO2002004621A2 Methods of creating constructs useful for introducing sequences into embryonic stem cells |
01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
01/17/2002 | WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
01/17/2002 | WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
01/17/2002 | WO2002004020A2 Pathogen resistance in organisms |
01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
01/17/2002 | WO2002003786A1 Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same |
01/17/2002 | WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
01/17/2002 | WO2001049106A3 Method for cloning animals with targetted genetic alterations |
01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
01/17/2002 | WO2001023541A3 Compositions and methods for altering gene expression |
01/17/2002 | US20020007197 Method for testing a technique intended to predict onset of heart arrhythmia using an animal test subject |
01/17/2002 | US20020005076 System and method of flow cytometry and sample handling |
01/17/2002 | CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors |
01/17/2002 | CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
01/17/2002 | CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |
01/16/2002 | EP1172375A1 Gene expression, genome alteration and reporter gene expression in myofibroblasts and myofibroblasts-like cells by using the regulatory regions within the alpha smooth muscle alpha-actin gene |
01/16/2002 | EP1171628A2 Compound screening methods |
01/16/2002 | EP1171609A2 Lipoxygenase proteins and polynucleotides encoding the same |
01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
01/16/2002 | EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
01/16/2002 | EP1170994A1 Transgenic animals expressing salivary proteins |
01/16/2002 | EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
01/15/2002 | US6339183 A vector containing a promoter linked to a heterologous gene that directs expression into the urogenital epithelium of transgenic animals, turning the bladder into a bioreactor; for recovering biologically active molecules from urine |
01/15/2002 | US6338220 Eradication of mosquitoes |
01/10/2002 | WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
01/10/2002 | WO2002002769A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
01/10/2002 | WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells |
01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
01/10/2002 | WO2002001950A2 Transgenic mice containing targeted gene disruptions |
01/10/2002 | WO2002001949A2 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof |
01/10/2002 | WO2001085973A9 Antisense type gene trap vector |
01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
01/10/2002 | WO2001050883A3 Rearing of aquatic species with dha-rich prey organisms |
01/10/2002 | WO2001048483A3 Method for screening of appetite control agents |
01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
01/10/2002 | WO2001017344A3 A method of transgenic fowl construction |
01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
01/10/2002 | WO2000075300A3 Methods for manipulating the avian genome |
01/10/2002 | US20020004938 Models of prion disease |
01/10/2002 | US20020004937 Method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
01/10/2002 | US20020004240 Method and system for introducing a gene into a human stem cell |
01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
01/09/2002 | EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility |
01/09/2002 | EP1169475A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy |
01/09/2002 | EP1169472A2 Compound assay using nematodes |
01/09/2002 | EP1169471A2 Method for screening compounds using nematode worms |
01/09/2002 | EP0959907A4 The butyrophilin gene promoter and uses thereof |
01/09/2002 | CN1329822A Electrostatic method and equipment for processing silk moth eggs |
01/08/2002 | US6337391 Polycation-sensing receptor in aquatic species and methods of use |
01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
01/03/2002 | WO2002000262A2 Modulation of chromosome function by chromatin remodeling agents |
01/03/2002 | WO2002000017A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
01/03/2002 | WO2002000016A1 Altered wool and hair fibres |
01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
01/03/2002 | WO2001039799A3 Passive desensitization |
01/03/2002 | US20020001842 Cytoplasmic transfer to de-differentiate recipient cells |